Recent work by Yang et al. (247) showed that blocking ACAT1 activates T cells; ACAT blockage increases PM cholesterol levels and enhances T-cell receptor clustering and signaling, which in turn potentiates effector function and proliferation of these cells to suppress tumor growth in mice. The gene discussed is ACAT1; the disease is neoplasm.